Nanalysis Scientific Corp. (NSCI.V)
| Previous Close | 0.7700 |
| Open | 0.7700 |
| Bid | 0.7000 x N/A |
| Ask | 0.7200 x N/A |
| Day's Range | 0.6900 - 0.7700 |
| 52 Week Range | 0.6300 - 1.5300 |
| Volume | |
| Avg. Volume | 63,901 |
| Market Cap | 65.934M |
| Beta (5Y Monthly) | 1.18 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0420 |
| Earnings Date | Nov 30, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2.75 |
- CNW Group
Nanalysis Reports Third Quarter 2022 Results
Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR machines and MRI technology for healthcare and industrial applications, releases its second quarter results ending September 30, 2022. Chief Executive Officer, Sean Krakiwsky and Interim Chief Financial Officer, Randall McRae will host a conference call at 5 P.M. Eastern Time today to discuss the results. A second call will be held for European investors at 8:30am ET on Wednesday, November
- CNW Group
Nanalysis Announces Third Quarter 2022 Conference Call
Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1, a leader in portable NMR machines and MRI technology for healthcare and industrial applications announces that on Tuesday, November 29th, 2022, the Company will put out a press release and Chief Executive Officer Sean Krakiwsky and Interim Chief Financial Officer Randall McRae will host a conference call at 5:00 P.M. Eastern Time to discuss the results for the quarter ending September 30, 2022.
- CNW Group
Nanalysis Provides Corporate Update
Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for healthcare and industrial applications, provides a corporate update on operations.
